An Interim Report of the Efficacy and Safety of Anisoylated Plasminogen Streptokinase Activator Complex (APSAC)1
- 1 January 1987
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 33 (3), 298-311
- https://doi.org/10.2165/00003495-198700333-00058
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Treatment of Acute Myocardial Infarction with Anisoylated Plasminogen Streptokinase Activator Complex in a District HospitalDrugs, 1987
- Systemic Effects of Anisoylated Plasminogen Streptokinase Activator Complex and Streptokinase Therapy in Acute Myocardial InfarctionDrugs, 1987
- Randomised Multicentre Trial of Anisoylated Plasminogen Streptokinase Activator Complex versus HeparinDrugs, 1987
- Reperfusion in Acute Myocardial InfarctionDrugs, 1987
- Intravenous Anisoylated Plasminogen Streptokinase Activator Complex versus Intravenous Streptokinase in Evolving Myocardial InfarctionDrugs, 1987
- Dose-Ranging Studies of Anisoylated Plasminogen Streptokinase Activator ComplexDrugs, 1987
- Early Clinical Evaluation of the Intravenous Treatment of Acute Myocardial Infarction with Anisoylated Plasminogen Streptokinase Activator ComplexDrugs, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985